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Abstract 
There is increasing evidence relating thalamic changes to the generation and/or 
maintenance of neuropathic pain. We have recently reported that neuropathic orofacial pain 
is associated with altered thalamic anatomy, biochemistry and activity, which may result in 
disturbed thalamocortical oscillatory circuits. Despite this evidence, it is possible that these 
thalamic changes are not responsible for the presence of pain per se, but result as a 
consequence of the injury. To clarify this subject, we compared brain activity and 
biochemistry in 12 people with below-level neuropathic pain after complete thoracic spinal 
cord injury to 11 people with similar injuries and no neuropathic pain and 21 age and gender 
matched healthy controls. Quantitative arterial spinal labelling was used to measure thalamic 
activity and magnetic resonance spectroscopy was used to determine changes in neuronal 
variability quantifying N-acetylaspartate and alterations in inhibitory function quantifying 
gamma amino butyric acid. This study revealed that the presence of neuropathic pain is 
associated with significant changes in thalamic biochemistry and neuronal activity. More 
specifically, the presence of neuropathic pain following spinal cord injury is associated with 
significant reductions in thalamic N-acetylaspartate, gamma amino butyric acid content and 
blood flow in the region of the thalamic reticular nucleus. Spinal cord injury on its own did not 
account for these changes. These findings support the hypothesis that neuropathic pain is 
associated with altered thalamic structure and function, which may disturb central processing 
and play a key role in the experience of neuropathic pain. 
 
 
  
Introduction  
 
Pain is a common and debilitating consequence of spinal cord injury (SCI) [52]. 
Although several types of pain can develop following SCI, neuropathic pain is one of the 
most intractable and the most prevalent, occurring in almost 50% of individuals following SCI 
and may be due to damage to the spinal cord or nerve roots [41]. Although the mechanisms 
responsible for generating SCI neuropathic pain remain unknown, some have suggested 
that activity within the spinal cord itself is important. For example, it has been hypothesized 
that SCI neuropathic pain results from on-going activity in intact residual spinothalamic tract 
pathways [50], or from an ‘irritated focus’ immediately above the injury [22]. Although such 
factors may help maintain neuropathic pain, they do not appear essential since complete 
sensory blockade or verified surgical removal of several spinal cord segments immediately 
above the injury, fail to relieve the pain in a considerable proportion of SCI subjects [4; 24]. 
These observations strongly suggest that neuropathic SCI pain may ultimately result from 
supraspinal alterations. 
There is increasing evidence for a critical role of the thalamus in the generation 
and/or maintenance of neuropathic pain. For example, neuropathic pain is associated with 
altered thalamic anatomy [10; 12], altered thalamic biochemistry [12; 28] and decreased 
thalamic perfusion [12; 26; 27]. Furthermore, there is increasing evidence that neuropathic 
pain may be associated with thalamocortical dysrhythmia [21; 39; 48], which may result from 
altered inhibitory output from the thalamic reticular nucleus (TRN) [18; 31]. Consistent with 
the hypothesis, we have recently shown decreased thalamic gamma amino butyric acid 
(GABA) content and decreased perfusion in the region of the TRN in individuals with 
orofacial neuropathic pain [12]. 
Despite this evidence, it is possible that these thalamic changes (decreased GABA, 
perfusion, gray matter volume and neuronal viability) are not responsible for the presence of 
pain per se, but result as a consequence of deafferentation. Indeed, there is evidence that 
although thalamic ventroposterior lateral (VPL) neurons in spinally injured rats exhibit 
increased burst firing, this dysrhythmia is linked to spinal injury and not to the presence of 
behaviours suggesting pain in animal models [9; 20]. Furthermore, we have previously 
reported that VPL thalamic anatomy was significantly altered in both SCI subjects with and 
without neuropathic pain, although a significantly greater change occurred in those with pain 
[10]. This raises the prospect that in neuropathic pain subjects, the injury itself may result in 
altered thalamic activity and biochemistry. Determining this distinction is important since 
future improvements in treatment are likely to hinge on our understanding of the neural 
mechanisms responsible for neuropathic pain. 
To resolve this issue, we measured thalamic perfusion and biochemistry in both 
complete thoracic SCI individuals with and without neuropathic pain and in healthy controls. 
We hypothesised that individuals with SCI neuropathic pain would have reduced thalamic 
neuronal density (VP), GABA content and regional perfusion (TRN). Further, we 
hypothesised that in individuals without pain, both those with SCI and in healthy controls, no 
significant change in any of these parameters would occur. 
 
 
Methods 
 
Subjects 
Twenty two subjects with established complete thoracic SCI (16 males; mean [±SEM] 
age 54±3 years) and 21 age and gender matched controls without pain or spinal cord injury 
(13 males; mean age 51±2 years) were recruited for the study. For the SCI subjects, the 
neurological level of injury was determined using the American Spinal Injury Association 
(ASIA) Impairment Scale (AIS) [23]. Each subject was examined by a clinician (P.W.) in the 
research group. The standardized AIS examination protocol was used to determine the most 
caudal level of the spinal cord with normal sensory and motor function on both sides of the 
body. An injury was termed complete when there was an absence of sensory and motor 
function in the lowest sacral segments. Twelve (8 males; mean age 57±4 years) of the 22 
SCI subjects experienced persistent neuropathic pain. All 12 SCI subjects had below-level 
neuropathic pain as defined by the International Association for the Study of Pain SCI pain 
taxonomy [42]. These subjects experienced continuous burning pain with intermittent 
stabbing and electric shock-like sensations in the region of sensory loss at least three 
segments below the neurological level of injury (Figure 1). To assess the intensity of their 
pain, each subject completed a pain diary in which they indicated, with a vertical pencil 
stroke on a 10 cm horizontal line, the intensity of their pain (0cm = ”no pain” to 10cm = 
”maximum imaginable pain”) three times a day for the week prior to the scanning session. 
These pain diary values were averaged to provide an indication of each subject’s chronic 
pain rating. Each subject also rated their ongoing pain intensity during the MRI scanning 
session (Table 1). The remaining 10 SCI subjects (8 males; mean age 50±4 years) did not 
have chronic neuropathic pain (Figure 2). The frequency of non-neuropathic pain did not 
differ between the two SCI groups. No significant differences in age (p=0.17) was found 
between SCI with pain and SCI without pain subjects. Both SCI groups were not significantly 
different in age compared to healthy controls (SCI with pain vs controls: p=0.18; SCI without 
pain vs controls: p=0.69). Informed written consent was obtained for all procedures and the 
study was approved by the institutional Human Research Ethics Committees. 
 
MRI acquisition 
Quantitative arterial spin labelling: 
Subjects lay supine head first on the bed of a 3T MRI scanner (Philips, Intera) with 
their head immobilized in a tight-fitting eight-channel head coil. An isotropic 3D scan 
covering the whole brain was acquired (turbo field echo; echo time=2.5 ms; repetition time: 
5600ms; flip angle: 8°; voxel size: 0.8x0.8x0.8mm). Whole brain cerebral blood flow (CBF) 
maps were then acquired using quantitative arterial spin labelling. The pulsed qASL version 
called QUASAR was used for this study and the sequence and subsequent CBF 
quantification has been described in details elsewhere [29; 30]. In short, the sequence is a 
multi-slice, multiple time-points capable sequence based on pulsed qASL and a Look-Locker 
readout. In addition, the sequence acquires data with and without vascular crushers 
(gradients) (Velocity cutoff = 4cm/s) which allows the estimation of the arterial input function 
on a regional level. CBF is subsequently estimated by model free deconvolution, similar to 
what is done for gadolinium perfusion scans [29]. By adding a few dynamics at a lower flip 
angle, correct B1, T1 and M0 of tissue can be obtained which is subsequently used for CBF 
quantification [30]. General scan parameters were: repetition time (TR): 4000ms echo time 
(TE): 23ms, ΔTI: 300ms, TI1: 40ms, 13 inversion times (40-3640ms), 64×64 matrix, 7 slices, 
slice thickness: 6mm, 2mm gap, field of view (FOV): 240×240, flip-angle: 35/11.7°, SENSE: 
2.5, 84 averages (48 with crusher: 4cm/s, 24 without crushers, 12 low flip angle, all 
implemented in a single sequence with a scan duration of 5min 52s. 
 
Functional magnetic resonance imaging (fMRI) 
In order to accurately place the 1H-MRS voxel in the somatosensory thalamus, we 
functionally defined the VPL thalamic nucleus in a group of 20 healthy subjects (14 males, 
mean [±SEM] age 43±3 years). A continuous series of 130 gradient echo, echo-planar fMRI 
image volumes using blood oxygen level dependent contrast were collected. Each image 
volume contained 43 axial slices covering the entire brain (voxel = 1.95 x 1.95 x 3.00 mm 
thick, repetition time = 3000ms; echo time = 40 ms). During each fMRI series, the right big 
toe pad was brushed innocuously using a plastic brush at approximately 2 strokes/second. 
Each of these stimulation paradigms were performed for a period of 10 fMRI volumes (30 
seconds) following a baseline period of 10 fMRI volumes (30 seconds). This was repeated a 
further 5 times for a total of 6 stimulation and 7 baseline periods. 
Magnetic resonance spectroscopy: 
GABA-edited MEGA-PRESS spectra 
Multi-planar (axial, sagittal, coronal) reformats were used for voxel placement. 
GABA-edited MEGA-PRESS spectra [6; 25] were acquired from a voxel (20x20x20 mm3) 
which was centred in each subject in the thalamus. We collected multiple pilot spectra to 
determine the minimum single voxel seize with reasonable signal-to- noise ratio. Since 11 of 
12 subjects with pain had bilateral pain and the remaining subject had pain on the left side 
only, we collected MRS data from the right thalamus only. The MEGA-PRESS sequence 
parameters were as follows: TR: 2000ms, TE: 68ms, 1024 acquisition points, total 
acquisition time: 27min. 100 averages were acquired with the MEGA pulse centred at 
1.9ppm (“ON spectra”) and 100 averages with the pulse centred at 7.6ppm (“OFF spectra”). 
Automatic shimming (pencilbeam auto first order option) was performed resulting in line 
widths of <10Hz for all spectra. 
 
Proton magnetic resonance spectra (1H-MRS) 
Proton magnetic resonance spectra (1H-MRS) were acquired from a voxel 
(15x10x15mm3) centred in the right ventral posterior lateral (VPL) thalamus. We collected 
multiple pilot spectra to determine the minimum single voxel seize with reasonable signal-to- 
noise ratio. The 1H-MRS sequence parameters were as follows: TR: 2000ms, TE: 29ms, 
1024 acquisition points, spectral width of 2kHz, total acquisition time: 9min. Automatic 
shimming (pencilbeam auto second order option) was performed resulting in line widths of 
<10Hz for all spectra. 
 
 
MRI analysis 
Quantitative arterial spin labelling 
QASL images were opened using custom software developed by Petersen and 
colleagues [29] and CBF maps created. In addition, from the CBF maps, anatomical 
(grey/white) image sets were created. These anatomical images were then co-registered to 
the T1-weighted anatomical image set collected at the same slice locations and the resulting 
parameters applied to the CBF maps. The T1-weighted anatomical images were then 
normalized to the standard MNI template and the normalization parameters applied to the 
CBF maps. The resulting spatially-normalized CBF maps were then smoothed using a 6mm 
full-width-at-half-maximum Gaussian filter. One healthy subject had to be excluded due to 
excessive head movement. Significant differences in CBF within the thalamus between SCI 
subjects with neuropathic pain and SCI subjects without pain were determined using a 
random effects procedure (uncorrected p<0.005, minimum cluster size 10 voxels, age and 
gender as nuisance variables, whole thalamus mask). CBF values from significant clusters 
were extracted from the SCI subjects with neuropathic pain, SCI subjects without pain and 
control subjects and compared using independent t tests (p<0.05). Furthermore, in SCI 
subjects with neuropathic pain, a one-tailed Pearson correlation test was used to determine 
significant (p<0.05) correlations between CBF values (thalamus cluster right) and thalamic 
biochemical ratios. Since these correlations were planned, we did not consider Bonferroni 
correction. Finally, in SCI subjects with neuropathic pain, correlations between CBF values 
and diary pain intensity, scan pain intensity and pain duration were determined (one-tailed 
Pearson correlation). To account for the cumulative α error due to multiple comparisons 
[three imaging modalities (QASL, NAA, GABA) correlated to three pain variables (scan pain, 
diary pain, pain duration), all of the results were corrected using the Bonferroni method 
(p˂0.05/9). The statistical analysis was performed with SPSS version 19.0 (IBM SPSS 
Statistics). 
 
Functional magnetic resonance imaging (fMRI) 
FMRI images were processed using SPM8 software. The images were motion 
corrected, global signal drifts removed using linear detrending, spatially normalized to the 
Montreal Neurological Institute (MNI) template and spatially smoothed using a 6mm full-
width-at-half-maximum Gaussian filter. Using a repeated box car model convolved with 
hemodynamic delay function, significant increases in fMRI signal intensity related to 
brushing the big toe were determined (random effects, corrected p<0.05, minimum cluster 
10 voxels). For each subject, the percent changes in signal intensity were calculated in each 
significant cluster. These signal changes were then averaged (±SEM) across the group to 
create a group time trend. For display purposes, the statistical maps were overlaid onto an 
individual subject’s T1-weighted anatomical image. 
 
Magnetic resonance spectroscopy 
GABA-edited MEGA-PRESS spectra 
For quantification of the GABA/creatine ratios the acquired spectra were analysed 
using the Java-based magnetic resonance user’s interface (jMRUI 4.0, European Union 
project). First, the dominant water resonance was removed using the Hankel Lanczos 
Singular Valve Decomposition algorithm. The ‘‘ON’’ and ‘‘OFF’’ spectral subsets were 
summed producing single ‘‘ON’’ and ‘‘OFF’’ 68 ms sub-spectra for each spectra dataset. 
These 68 ms sub-spectra were then subtracted resulting in GABA-edited difference spectra 
to measure GABA concentration at 3.01 ppm. The GABA-edited difference spectra were 
then phased with respect to both the zero- and first-order phase. GABA was quantified using 
AMARES, a nonlinear least-square fitting algorithm operating in the time domain. Peak fitting 
for GABA was performed after manually defining the centre frequency and line width of the 
GABA peak, and modelling the GABA peak as a singlet. Furthermore, Lorentzian curves 
were used to obtain the peak amplitude for this resonance. 
The ‘‘OFF’’ spectral subsets were summed producing single ‘‘OFF’’ 68 ms sub-
spectra for each spectra dataset to measure Creatine (Cr) concentration at 3.02 ppm. The 
single ‘‘OFF’’ 68 ms sub-spectra was then phased with respect to both the zero- and first-
order phase. Line broadening of 5 Hz was used to improve the display. Spectral fitting in 
AMARES was performed after manually defining the centre frequency and line width of the 
Cr peak, and modelling the Cr peak as a singlet. Furthermore, Gaussian curves were used 
to obtain the peak amplitude for this resonance.  
Finally, ratios were calculated for GABA relative to Cr. Differences in metabolite 
ratios between SCI subjects with persistent neuropathic pain and SCI subjects without pain 
and healthy controls were determined using independent t tests (p<0.05). Furthermore, in 
SCI subjects with neuropathic pain a one-tailed Pearson correlation (Bonferroni corrected) 
was used to determine significant (p˂0.05/9) correlations between GABA/Cr ratios and the 
mean pain intensity scores for the week prior to scanning (diary pain), during scanning (scan 
pain) and pain duration. The statistical analysis was performed with SPSS version 19.0 (IBM 
SPSS Statistics). Two SCI subjects with pain had to be excluded due to excessive head 
movement.  
 
Proton magnetic resonance spectra (1H-MRS) 
MRS data were analysed in the time domain using the Java-based magnetic 
resonance user’s interface (jMRUI 4.1, European Union project). First, the dominant water 
resonance was removed using the Hankel Lanczos Singular Valve Decomposition algorithm. 
All metabolite resonances were quantified using QUEST (containing a 29 ms TE metabolite 
basis set including N-acetyl aspartate (NAA), Cr, aspartate, glutamate, glutamine, myo-
inositol (Ml) and glycerolphosphocholine [5]. Ratios were calculated for NAA relative to Cr. 
Using SPSS version 19.0 (IBM SPSS Statistics), significant differences in metabolite ratios 
between SCI subjects with pain, SCI without pain and healthy controls were determined 
using independent t tests (p<0.05). Furthermore, in SCI subjects a one-tailed Pearson 
correlation test was used to determine significant (p<0.05) correlations between NAA/Cr 
ratios and GABA/Creatine ratios. Finally, in SCI subjects with neuropathic pain, a one-tailed 
Pearson correlation test (Bonferroni corrected) was used to determine significant (p<0.05/9) 
correlations between NAA/Cr ratios and diary pain, scan pain and pain duration. One SCI 
subject with neuropathic pain, one SCI without pain and two healthy subjects had to be 
excluded due to excessive head movement.  
 
 
Results 
 
Individual and mean subject characteristics are shown in Table 1. On average, SCI 
subjects had on-going pain intensity (diary pain) of 5.2±0.7, pain intensity during scanning 
(scan pain) 3.6±0.8 and an average pain duration of 182.4±41.8 months. Eleven out of 12 
SCI subjects had bilateral below-level neuropathic pain and one subject (SCI subject 7) had 
left sided below-level neuropathic pain. 
 
Thalamic blood flow 
Individuals with SCI neuropathic pain had significantly reduced CBF within the right 
thalamus compared to SCI subjects without pain (p=0.004) and healthy controls (p=0.01) 
(mean [±SEM] CBF ml/min/g: controls: 28.1±2.4; SCI without pain: 30.9±3.1; SCI with pain: 
18.7±2.3). This CBF decrease was located on the lateral edge of the thalamus, including the 
region of the thalamic reticular nucleus (Figure 3), however, it is pertinent to know that other 
thalamic nuclei may also be encompassed. More specifically, it was located in the anterior 
dorsal aspect of the thalamic reticular nucleus, which in monkeys, receives collaterals from 
VP thalamic neurons [32]. In SCI subjects with neuropathic pain, thalamic reticular nucleus 
blood flow was not correlated to GABA/CR ratios (r=-0.28, p=0.22) and NAA/CR ratios (r=-
0.02, p=0.49). Furthermore, thalamic reticular nucleus blood flow was not significantly 
correlated to diary pain (r=-0.24, p=0.23), scan pain (r=0.36, p=0.13) or pain duration 
(r=0.29, p=0.18).  
 
Brain activation in response to brushing 
Brushing of the right big toe in healthy controls evoked significant signal intensity 
increases in the contralateral VPL thalamus. Figure 3A shows the location of this thalamic 
activation overlaid onto an individual subject’s T1-weighted anatomical image set. The mean 
(±SEM) signal intensity changes over time for this VPL cluster is shown in Figure 3B. It is 
clear that during each brushing period, signal intensity increased and returned to baseline in 
the intervening rest periods. 
Thalamic GABA levels 
The thalamic region from which GABA spectra were acquired as well as a typical 
spectrum are shown in Figures 4A and 4B. SCI subjects with neuropathic pain had 
significantly lower thalamic GABA levels compared with SCI subjects without pain (mean 
[±SEM] GABA/Cr ratio x10-3: SCI subjects with pain: 1.7±0.2; SCI subjects without pain: 
2.4±0.1; p<0.001) and controls (controls: 2.4±0.2; p<0.001) (Figure 4C). Individual GABA/Cr 
ratios are shown in Table 2. In SCI subjects with neuropathic pain, GABA/Cr ratios were not 
correlated to either diary pain (r=0.15, p=0.34), scan pain (r=0.07, p=0.42), or pain duration 
(r=-0.54, p=0.06).  
 
Thalamic NAA levels 
The thalamic region from which NAA spectra were acquired as well as a typical 
spectrum are shown in Figures 5A and 5B. SCI subjects with neuropathic pain had 
significantly lower thalamic NAA levels compared with SCI subjects without pain (mean 
[±SEM] NAA/Cr ratio: SCI subjects with pain: 1.19±0.03; SCI subjects without pain: 
1.40±0.07; p=0.02) and controls (controls: 1.32±0.03; p=0.005) (Figure 5C). Individual 
NAA/Cr ratios are shown in Table 2. In SCI subjects with neuropathic pain, NAA/Cr ratios 
were positively correlated to GABA/CR ratios (r=0.59, p=0.04), that is the greater the 
reduction in thalamic NAA levels, the greater the reduction in thalamic GABA. Furthermore, 
in SCI subjects with neuropathic pain NAA/Cr ratios were not correlated to either scan pain 
(r=0.60, p=0.03), diary pain (r=0.31, p=0.18) or pain duration (r=-0.10, p=0.39) when 
Bonferroni corrected.  
 
Discussion 
 
This study demonstrates that the presence of neuropathic pain following SCI is 
associated with significant changes in thalamic biochemistry and on-going neuronal activity. 
More specifically, the presence of neuropathic pain following SCI and not SCI itself is 
associated with significant reductions in thalamic NAA (a marker of neural viability) [35], 
GABA content and blood flow. However, it is pertinent to note that we do acknowledge that 
this reduction in blood-flow may also encompass other thalamic nuclei. These findings 
support the hypothesis that neuropathic pain is associated with altered thalamic structure 
and function that are likely to disturb central processing and play a key role in the experience 
of persistent pain. Specifically, it has been shown that neuropathic pain following SCI is 
associated with changes in thalamic neurons which subsequently may make these neurons 
hyperexcitable and as such they may act as a pain generator or amplifier [16; 51; 53].  
A significant strength of this study is that it has been demonstrated that both 
chemical and functional thalamic alterations are exclusively associated with neuropathic pain 
and not the injury itself. Indeed, although all our SCI subjects had the same type and level of 
injuries (complete injury, thoracic level), those subjects that did not develop below-level 
neuropathic pain, displayed no changes in thalamic GABA, NAA concentration or blood flow. 
It is thought that NAA is localized almost exclusively in mature neurons and neuronal 
processes and is considered a putative marker of the number and viability of neurons [46]. 
Despite limited signal to noise ratios required us to obtain proton spectra from a region larger 
than the VP thalamus, we are confident that the NAA changes result largely from VP 
anatomical changes, since we have shown that SCI is associated with fractional anisotropy 
changes centred on the VP thalamus which are exacerbated in those with neuropathic pain 
[10]. Although a change in fractional anisotropy can result from neuronal loss, our finding 
that only SCI subjects with neuropathic pain had reduced NAA in the region of the VP 
thalamus, compared with SCI subjects without pain and controls, suggests that SCI itself 
does not result in a decrease in neuronal viability within the VP thalamus. Thalamic 
reorganization after peripheral deafferentation in the macaque is well known [33] and 
therefore the lack of change following SCI is surprising given the substantial deafferentation 
that has occurred and highlights the significance of decreased thalamic neural viability on 
the presence of neuropathic pain following SCI. 
It is well known that VP thalamic output neurons that project to the primary 
somatosensory cortex also send collaterals to the thalamic reticular nucleus (TRN), which in 
turn sends inhibitory efferents back to the VP thalamus [31]. Consistent with a postulated 
role for these collaterals in modulating pain through inhibitory feedback mechanisms, we 
found that SCI pain is associated with decreased blood flow in the region of the TRN. More 
specifically, this blood flow reduction is located in the TRN region that responds to 
somatosensory stimulation and overlaps with the TRN blood flow decrease that occurs in 
individuals with orofacial neuropathic pain [12; 32]. Although human brain imaging 
investigations measuring evoked neuronal function (fMRI BOLD) have revealed that acute 
pain is associated with activation of a number of brain regions, including the thalamus, 
somatosensory, insular and cingulate cortices [7], chronic neuropathic pain does not appear 
to be associated with an increase in thalamic CBF [26]. Indeed, investigations measuring 
spontaneous neuronal function (positron emission tomography) have consistently reported 
on-going activity decreases in the thalamus [13; 15; 26]. Our data supports these previous 
findings and extends them by showing that the decrease in thalamic activity may be derived 
from reduced activity within the TRN, likely resulting from reduced on-going drive from the 
VP thalamic nucleus.  
Immunohistochemical investigations have shown that the TRN contains almost 
exclusively GABAergic neurons [18; 31]. Consistent with these findings, we found that SCI 
subjects with neuropathic pain have reduced thalamic GABA content which is also 
consistent with our previous findings in orofacial neuropathic pain patients [12]. The 
decreased thalamic GABA could result from reduced presynaptic GABA production or 
increased GABA reuptake and catabolism. Consistent with our findings in humans, Ralston 
and colleagues demonstrated in the macaque that somatosensory pathway lesions reduce 
GABA-immunoreactive synapses within the VP thalamus [36]. Furthermore, Rausell and 
colleagues showed in the macaque that peripheral nerve lesions result in GABA receptor 
down-regulation within the VP thalamus and an increase in activity of calbindin cells 
preferentially innervated by central pain pathways [37]. Although pain behaviours were not 
measured in these previous macaque studies, our data suggests that the GABAergic 
changes may underlie the presence of pain, since our SCI subjects without pain did not 
show any change in thalamic GABA content. 
It has been hypothesised that the TRN alters brain function by regulating all sensory 
information, apart from olfaction, that passes through the thalamus on its way to the cerebral 
cortex [18; 31]. Indeed it was hypothesized by Crick nearly 30 years ago that the TRN may 
regulate internal attentional processes, i.e. the searchlight hypothesis [3]. Although not 
conclusive, thalamocortical and TRN neurons also appear to be critical for the production of 
thalamocortical rhythmic oscillations with evidence that the intrinsic and network properties 
of TRN neurons endow them with oscillatory properties [21]. For example, Steriade and 
colleagues [43] reported spindle-related rhythms in disconnected TRN neurons and abolition 
of spindle oscillations following TRN lesion. Additionally, reciprocal connections between 
excitatory relay neurons and local inhibitory neurons may be involved in generating 
thalamocortical oscillations [14; 45]. It has recently emerged that chronic neuropathic pain, 
including neuropathic pain following SCI, is associated with significantly altered 
thalamocortical rhythmic oscillations, characterized by higher spectral power in the 2-25Hz 
range and a shift of the dominant peak towards lower frequencies [2; 39; 48]. Furthermore, 
this altered rhythm is characterized by persistent theta and beta over-activations in pain-
associated areas, including the primary and secondary somatosensory cortical regions [44].  
Consistent with this, we have recently shown in orofacial neuropathic pain subjects, 
that reduced thalamic GABA content was negatively correlated to thalamocortical functional 
connectivity. That is, the greater the loss of thalamic GABA, the stronger the signal coupling 
between the VP thalamus and brain areas including the primary and secondary 
somatosensory cortices and the anterior insula [12]. This thalamocortical connectivity may 
take time to establish since it has been shown in an animal model of SCI pain that VP-SI 
connectivity initially decreases [40]. These data support the idea that chronic neuropathic 
pain is associated with altered thalamocortical activity [39; 47; 48] and raises the possibility 
that at least some forms of chronic neuropathic pain are not associated with overall 
increases in activity in “acute pain-related” brain regions, but instead changes in connectivity 
strengths. 
It has been hypothesized that altered thalamocortical rhythm associated with chronic 
pain results from altered thalamic firing patterns [17]. Studies in both humans [11; 19] and in 
an animal model of neuropathic SCI pain reveal that neuropathic pain is associated with 
increased frequency of burst firing in VP thalamic neurons [1; 9; 38; 49]. In addition, in an 
animal model of diabetic neuropathic pain it was demonstrated that neuropathic pain is 
associated with enhanced spontaneous activity of VPL neurons [8]. Although, this abnormal 
bursting is not definitively tied to the presence of neuropathic pain [34] it has been 
hypothesised that this altered activity is associated with thalamocortical dysrhythmia and the 
experience of pain [21]. Although we did not measure VP thalamic firing, our data are 
consistent with the idea that altered VP thalamic regulation by the TRN is associated with 
the presence of neuropathic pain.  
Despite no correlations between pain intensity variables (both diary and scan pain 
have been calculated from the average of continuous burning pain and intermittent stabbing 
and electric shock-like sensations) and plastic changes were determined, it is pertinent to 
note that by separating both pains (continuous burning pain and intermittent stabbing and 
electric shock-like sensations), significant associations may have been emerged. 
Although the thalamic changes were significantly related to the presence of pain, there was 
no significant correlation between the changes and pain intensity in the time just prior to or during 
scanning. This suggests that chronic pain is associated with thalamic changes that may underlie the 
development and maintenance of pain. However, these changes are not directly linked to the 
intensity of pain at any particular moment.  
Further insights into the interplay between deafferentation, loss of inhibition, 
dysrhythmia and neuropathic pain are provided by the present study. Although no 
conclusions can be made regarding the nature of neuronal firing, there is certainly a 
reduction in GABA in the thalamus and a disruption to normal inhibitory function. As with 
other studies, the reduction in thalamic activity represented by a reduction in perfusion is 
consistent but nevertheless difficult to interpret. These results suggest however that a 
reduction in thalamic inhibitory function, possibly mediated by altered function of the TRN, 
results in an increase in thalamic outflow to cortical structures involved in pain processing.  
 
Acknowledgements: This work was supported by grants awarded by the Spinal Cord Injury 
and Related Neurological Conditions Research Grants Program, New South Wales 
Government, Australia, the National Health and Medical Research Council of Australia and 
the Australian and New Zealand College of Anaesthetists. The MRUI software package was 
kindly provided by the participants of the EU Network programmes: Human Capital and 
Mobility, [CHRX-CT94-0432] and Training and Mobility of Researchers, [ERB-FMRX-
CT970160]. The authors declare no competing financial interests 
 
References: 
[1] Bakkum BW, Henderson CN, Hong SP, Cramer GD. Preliminary morphological evidence that 
vertebral hypomobility induces synaptic plasticity in the spinal cord. J Manipulative Physiol 
Ther 2007;30(5):336-342. 
[2] Boord P, Siddall PJ, Tran Y, Herbert D, Middleton J, Craig A. Electroencephalographic slowing and 
reduced reactivity in neuropathic pain following spinal cord injury. Spinal Cord 
2007;46(2):118-123. 
[3] Crick F. Function of the thalamic reticular complex: the searchlight hypothesis. Proc Natl Acad Sci 
U S A 1984;81(14):4586-4590. 
[4] Davis L. Treatment of spinal cord injuries. American Medical Association Archives of Surgery 
1954;69:488-495. 
[5] Di Piero V, Ferracuti S, Sabatini U, Pantano P, Cruccu G, Lenzi GL. A Cerebral Blood Flow Study on 
Tonic Pain Activation in Man. Pain 1994;56:167-173. 
[6] Edden RAE, Barker PB. Spatial effects in the detection of γ-aminobutyric acid: Improved 
sensitivity at high fields using inner volume saturation. Magnetic Resonance in Medicine 
2007;58(6):1276-1282. 
[7] Farrell MJ, Laird AR, Egan GF. Brain activity associated with painfully hot stimuli applied to the 
upper limb: a meta-analysis. Hum Brain Mapp 2005;25(1):129-139. 
[8] Fischer TZ, Tan AM, Waxman SG. Thalamic neuron hyperexcitability and enlarged receptive fields 
in the STZ model of diabetic pain. Brain Research 2009;1268(0):154-161. 
[9] Gerke MB, Duggan AW, Xu L, Siddall PJ. Thalamic neuronal activity in rats with mechanical 
allodynia following contusive spinal cord injury. Neuroscience 2003;117:715-722. 
[10] Gustin SM, Wrigley PJ, Siddall PJ, Henderson LA. Brain anatomy changes associated with 
persistent neuropathic pain following spinal cord injury Cerebral Cortex 2010;20(6):1409-
1419. 
[11] Hains BC, Saab CY, Waxman SG. Alterations in Burst Firing of Thalamic VPL Neurons and 
Reversal by Nav1.3 Antisense After Spinal Cord Injury. Journal of Neurophysiology 
2006;95(6):3343-3352. 
[12] Henderson LA, Peck CC, Petersen ET, Rae CD, Youssef AM, Reeves JM, Wilcox SL, Akhter R, 
Murray GM, Gustin SM. Chronic Pain: Lost Inhibition? The Journal of Neuroscience 
2013;33(17):7574-7582. 
[13] Hsieh JC, Belfrage M, Stone-Elander S, Hansson P, Ingvar M. Central representation of chronic 
ongoing neuropathic pain studied by positron emission tomography. Pain 1995;63(2):225-
236. 
[14] Huguenard JR, McCormick DA. Thalamic synchrony and dynamic regulation of global forebrain 
oscillations. Trends in Neurosciences 2007;30(7):350-356. 
[15] Iadarola MJ, Max MB, Berman KF, Byas-Smith MG, Coghill RC, Gracely RH, Bennett GJ. Unilateral 
decrease in thalamic activity observed with positron emission tomography in patients with 
chronic neuropathic pain. Pain 1995;63(1):55-64. 
[16] Jeanmonod D, Magnin M, Morel A. Low-threshold calcium spike bursts in the human thalamus - 
common physiopathology for sensory, motor and limbic positive symptoms. Brain 
1996;119(Part:2):2):363-375. 
[17] Jeanmonod D, Magnin M, Morel A, Siegemund M. Surgical control of the human thalamocortical 
dysrhythmia: 1. central lateral thalamotomy in neurogenic pain. Thalamus & Related 
Systems 2001;1:71-79. 
[18] Lam YW, Sherman SM. Functional organization of the thalamic input to the thalamic reticular 
nucleus. J Neurosci 2011;31(18):6791-6799. 
[19] Lenz FA, Kwan HC, Dostrovsky JO, Tasker RR. Characteristics of the bursting pattern of action 
potentials that occurs in the thalamus of patients with central pain. Brain Research 
1989;496:357-360. 
[20] Liang L, Mendell LM. Bilateral transient changes in thalamic nucleus ventroposterior lateralis 
after thoracic hemisection in the rat. Journal of Neurophysiology 2013;110(4):942-951. 
[21] Llinas RR, Ribary U, Jeanmonod D, Kronberg E, Mitra PP. Thalamocortical dysrhythmia: A 
neurological and neuropsychiatric syndrome characterized by magnetoencephalography. 
Proceedings of the National Academy of Sciences of USA 1999;96:15222-15227. 
[22] Loubser PG, Donovan WH. Diagnostic spinal anaesthesia in chronic spinal cord injury pain. 
Paraplegia 1991;29:25-36. 
[23] Marino RJ, Barros T, Biering-Sorensen F, Burns SP, Donovan WH, Graves DE, Haak M, Hudson 
LM, Priebe MM. International standards for neurological classification of spinal cord injury. J 
Spinal Cord Med 2003;26:S50–56. 
[24] Melzack R, Loeser JD. Phantom body pain in paraplegics: evidence for a central "pattern 
generating mechanism" for pain. Pain 1978;4:195-210. 
[25] Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing 
and water suppression. NMR in Biomedicine 1998;11(6):266-272. 
[26] Moisset X, Bouhassira D. Brain imaging of neuropathic pain. Neuroimage 2007;37 Suppl 1:S80-
88. 
[27] Ness TJ, San Pedro EC, Richards JS, Kezar L, Liu HG, Mountz JM. A case of spinal cord injury-
related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. 
Pain 1998;78:139-143. 
[28] Pattany PM, Yezierski RP, Widerström-Noga EG, Bowen BC, Martinez-Arizala A, Garcia BR, 
Quencer RM. Proton magnetic resonance spectroscopy of the thalamus in patients with 
chronic neuropathic pain after spinal cord injury. American Journal of Neuroradiology 
2002;23:901-905. 
[29] Petersen ET, Lim T, Golay X. Model-free arterial spin labeling quantification approach for 
perfusion MRI. Magnetic Resonance in Medicine 2006;55(2):219-232. 
[30] Petersen ET, Mouridsen K, Golay X. The QUASAR reproducibility study, Part II: Results from a 
multi-center Arterial Spin Labeling test–retest study. NeuroImage 2010;49(1):104-113. 
[31] Pinault D. The thalamic reticular nucleus: structure, function and concept. Brain Res Brain Res 
Rev 2004;46(1):1-31. 
[32] Pollin B, Rokyta R. Somatotopic organization of nucleus reticularis thalami in chronic awake cats 
and monkeys. Brain Res 1982;250(2):211-221. 
[33] Pons T, Garraghty P, Ommaya A, Kaas J, Taub E, Mishkin M. Massive cortical reorganization after 
sensory deafferentation in adult macaques. Science 1991;252(5014):1857-1860. 
[34] Radhakrishnan V, Tsoukatos J, Davis KD, Tasker RR, Lozano AM, Dostrovsky JO. A comparison of 
the burst activity of lateral thalamic neurons in chronic pain and non-pain patients. Pain 
1999;80:567-575. 
[35] Rae C. A Guide to the Metabolic Pathways and Function of Metabolites Observed in Human 
Brain 1H Magnetic Resonance Spectra. Neurochem Res 2013:1-36. 
[36] Ralston HJ, Ohara PT, Meng XW, Wells J, Ralston DD. Transneuronal changes of the inhibitory 
circuitry in the macaque somatosensory thalamus following lesions of the dorsal column 
nuclei. The Journal of Comparative Neurology 1996;371(2):325-335. 
[37] Rausell E, Cusick CG, Taub E, Jones EG. Chronic deafferentation in monkeys differentially affects 
nociceptive and nonnociceptive pathways distinguished by specific calcium-binding proteins 
and down-regulates gamma-aminobutyric acid type A receptors at thalamic levels. 
Proceedings of the National Academy of Sciences of USA 1992;89:2571-2575. 
[38] Saghaei E, Abbaszadeh F, Naseri K, Ghorbanpoor S, Afhami M, Haeri A, Rahimi F, Jorjani M. 
Estradiol attenuates spinal cord injury-induced pain by suppressing microglial activation in 
thalamic VPL nuclei of rats. Neuroscience Research 2013;75(4):316-323. 
[39] Sarnthein J, Stern J, Aufenberg C, Rousson V, Jeanmonod D. Increased EEG power and slowed 
dominant frequency in patients with neurogenic pain. Brain 2006;129(Pt 1):55-64. 
[40] Seminowicz DA, Jiang L, Ji Y, Xu S, Gullapalli RP, Masri R. Thalamocortical Asynchrony in 
Conditions of Spinal Cord Injury Pain in Rats. The Journal of Neuroscience 
2012;32(45):15843-15848. 
[41] Siddall PJ, Taylor DA, McClelland JM, Rutkowski SB, Cousins MJ. Pain report and the relationship 
of pain to physical factors in the first 6 months following spinal cord injury. Pain 1999;81(1-
2):187-197. 
[42] Siddall PJ, Yezierski RP, Loeser JD. Taxonomy and epidemiology of spinal cord injury pain. In: 
Yezierski RP, Burchiel KJ, editors. Spinal cord injury pain: assessment, mechanisms, 
management. . Progr Pain Res Manag 2002;23:9-24. 
[43] Steriade M, Deschenes M, Domich L, Mulle C. Abolition of spindle oscillations in thalamic 
neurons disconnected from nucleus reticularis thalami. J Neurophysiol 1985;54(6):1473-
1497. 
[44] Stern J, Jeanmonod D, Sarnthein J. Persistent EEG overactivation in the cortical pain matrix of 
neurogenic pain patients. Neuroimage 2006;31(2):721-731. 
[45] Trageser JC, Burke KA, Masri R, Li Y, Sellers L, Keller A. State-Dependent Gating of Sensory Inputs 
by Zona Incerta. Journal of Neurophysiology 2006;96(3):1456-1463. 
[46] Urenjak J, Williams SR, Gadian DG, Noble M. Proton nuclear magnetic resonance spectroscopy 
unambiguously identifies different neural cell types. J Neurosci 1993;13(3):981-989. 
[47] Walton KD, Dubois M, Llinás RR. Abnormal thalamocortical activity in patients with Complex 
Regional Pain Syndrome (CRPS) Type I. PAIN 2010;150(1):41-51. 
[48] Walton KD, Llinás RR. Central Pain as a Thalamocortical Dysrhythmia: A Thalamic Efference 
Disconnection? In: L Kruger, AR Light, editors. Translational Pain Research: From Mouse to 
Man. Boca Raton, FL: CRC Press, 2010. 
[49] Wang G, Thompson SM. Maladaptive Homeostatic Plasticity in a Rodent Model of Central Pain 
Syndrome: Thalamic Hyperexcitability after Spinothalamic Tract Lesions. The Journal of 
Neuroscience 2008;28(46):11959-11969. 
[50] Wasner G, Lee BB, Engel S, McLachlan E, Wasner G, Lee BB, Engel S, McLachlan E. Residual 
spinothalamic tract pathways predict development of central pain after spinal cord injury. 
Brain 2008;131(Pt 9):2387-2400. 
[51] Waxman SG, Hains BC. Fire and phantoms after spinal cord injury: Na+ channels and central 
pain. Trends in Neurosciences 2006;29(4):207-215. 
[52] Widerstrom-Noga EG, Felipe-Cuervo E, Broton JG, Duncan RC, Yezierski RP. Perceived difficulty 
in dealing with consequences of spinal cord injury. Archives of physical medicine and 
rehabilitation 1999;80(5):580-586. 
[53] Yezierski R. Spinal cord injury pain: Spinal and supraspinal mechanisms. . J Rehabil Res Dev 
2009;46(1):95-108. 
 
 
  
FIGURE LEGENDS 
Figure 1: Individual pain and injury diagrams for subjects with below-level spinal cord injury 
neuropathic pain. The light grey shading indicates each subject’s on-going neuropathic pain 
distribution. The cross hatching indicates areas of cutaneous hypersensitivity. The fine 
dashed line illustrates the neurological level of injury and the coarse dashed line the sensory 
zone of partial preservation (ZPP). The details of each subject are contained in Table 1. 
 
Figure 2: Individual pain and injury diagrams for subjects without neuropathic pain. None of 
these subjects had neuropathic pain or cutaneous hypersensitivity. The fine dashed line 
illustrates the neurological level of injury and the coarse dashed line the sensory zone of 
partial preservation (ZPP). The details of each subject are contained in Table 1.  
 
Figure 3: A; Cerebral blood flow (CBF) decreases (cool color scale) in the right thalamus of 
subjects with spinal cord injury (SCI) and neuropathic pain compared with SCI subjects 
without pain overlaid onto an individual’s axial and coronal T1-weighted anatomical images. 
The CBF decrease encompasses the region of the thalamic reticular nucleus (TRN). 
Functional blood flow increases (red color scale) in the ventroposterior lateral (VPL) 
thalamus during innocuously brushing the big toe in 20 healthy subjects. Slice locations in 
Montreal Neurological Institute space are indicated at the lower left of each image. B; Mean 
(±SEM) percentage changes in signal intensity in the VPL thalamus. The grey bars indicate 
the periods of innocuous brushing of the big toe. C; A plot of mean (±SEM) CBF in the TRN 
of SCI subjects with neuropathic pain, SCI subjects without pain and pain-free controls. D: 
Overlay of TRN CBF decrease in the right thalamus of SCI subjects with neuropathic pain 
and TRN CBF decrease in the contralateral (to pain) thalamus of subjects with painful 
trigeminal neuropathic pain (PTN) published previously (green shading) [12]. Note, the CBF 
TRN decreases in SCI subjects with neuropathic pain overlap CBF TRN decreases of 
subjects with PTN. 
 Figure 4: A; Axial slice showing location from which GABA-edited MEGA-PRESS 
spectroscopy was performed in the right thalamus of SCI subjects with SCI neuropathic pain, 
SCI subjects without pain and pain-free controls. Slice location in Montreal Neurological 
Institute space is indicated at the lower left of the image. B; Typical MEGA-PRESS spectrum 
obtained from the thalamus. Glx: glutamine; GABA: gamma-animobutyric acid; Cr: Creatine; 
ppm: parts per million; C: A plot of mean (±SEM) GABA/Cr ratios in the thalamus of SCI 
subjects with neuropathic pain, SCI subjects without neuropathic pain and pain-free controls. 
 
Figure 5: A; Axial slice showing location from which proton spectroscopy was performed in 
the right thalamus of SCI subjects with neuropathic pain, SCI subjects without pain and pain-
free controls. Slice location in Montreal Neurological Institute space is indicated at the lower 
left of the image. B; Typical proton spectrum obtained from the thalamus. PCr: 
Phosphocreatine; NAA: N-acetyl aspartate; Cr: Creatine; ppm: parts per million; C: A plot of 
mean (±SEM) NAA/Cr ratios in the thalamus of SCI subjects with neuropathic pain, SCI 
subjects without neuropathic pain and pain-free controls. 
 
Table 1: Spinal cord injury subject characteristics: Table indicating subject characteristics 
where neurological level injury = the most caudal segment of the spinal cord with normal 
sensory and motor function on both sides of the body; AIS = American Spinal Injury 
Association impairment scale where A = no motor or sensory function is preserved in the 
sacral segments S4-S5; motor/sensory level = the most caudal segment of the spinal cord 
with normal motor/sensory function; sensory ZPP = zone of partial sensory preservation, 
which indicates the most caudal dermatome that remains partially innervated; VAS = visual 
analogue score; SR = sustained release. 
 
